Page 125 - THE EVOLUTION OF EARLY ARTHRITIS AND CARDIOVASCULAR RISK Samina A. Turk

CHANGE IN CARDIOVASCULAR RISK
6
123
Females TC† Beta
HDL† LDL†
Beta Beta
(CI) and p-value (CI) and p-value
Trigly† TC:HDL ratio† Syst RR‡ Dia RR‡
Beta Beta Beta Beta
(CI) and p-value (CI) and p-value (CI) and p-value (CI) and p-value
(CI) and p-value
-0.01 <0.01
ESR (-0.02-0.00) (-0.01-0.00)
-0.01 <0.01 <0.01 (-0.01-0.00) (-0.01-0.01) (-0.01-0.01) 0.115* 0.802 0.757
0.02 0.01 0.02 (0.00-0.04) (-0.01-0.03) (-0.01-0.04)
<0.01 <0.01 (-0.17-0.18) (-0.10-0.11) 0.975 0.979
-0.25 0.12 (-0.34-0.84) (-0.26-0.51) 0.449 0.522
0.067* 0.160
0.02 -0.01 (-0.01-0.04) (-0.02-0.01) 0.156 0.417
0.063 0.465 0.250
-0.01 -0.004
CRP (-0.02-0.00) (-0.01-0.00)
-0.01 <0.01 <0.01 (-0.01-0.00) (-0.01-0.00) (-0.01-0.01) 0.022 0.283 0.944
-0.01 -0.01 0.01 (-0.04-0.01) (-0.04-0.02) (-0.02-0.05) 0.340 0.435 0.728
<0.01 -0.02 (-0.17-0.18) (-0.13-0.08) 0.958 0.691
0.16 0.10 (-0.60-0.92) (-0.35-0.55) 0.677 0.656
0.015 0.044
-0.03 -0.02 (-0.06-0.01) (-0.033-0.00) 0.145 0.098
CI: confidence interval, CRP: C-reactive protein, CV: cardiovascular, DAS: disease activity score, Dia RR: diastolic blood pressure, ESR: erythrocyte sedimentation rate, HDL: high-density lipoprotein, LDL: low-density lipoprotein, Syst RR: systolic blood pressure, TC: total cholesterol, trigly: triglycerides
Grey values: values after four weeks of treatment
* interaction with time p<0.10 †without statins
‡without antihypertensives